NEWS

/ NEWS / Axim Biotechnologies Goes With Grayling

Latest news from Grayling

Axim Biotechnologies Goes With Grayling

7th November 2016


Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.

Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.

Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.

Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”


Grayling Team

Latest News

30th June 2017


Grayling a perfect match for new dating app

Grayling’s San Francisco team recently began working with Belong, an innovative startup founded by Silicon Valley tech veterans, that aims to make dating more personal and successful for Bay Area...

Read More

12th June 2017


Uber adds contribution to Grayling Advantage Series

Andrew Gray, Director of Engineering for Uber ATG has added his perspective to Me, Myself and AI, Grayling’s look at the opportunities and risks presented by artificial intelligence. Gray was...

Read More

6th June 2017


Me, Myself and AI: Latest in Grayling Advantage Series identifies communications risks and opportunities with advancements in Artificial Intelligence

The potential advantages gained through the incorporation of artificial intelligence and automation into different industries will only be achieved if companies consider communications alongside the...

Read More